See All Slides - tctmd.com

Slides

Presentation ACC 2013

Randomized Trial of LAA Closure vs Warfarin for Stroke/ Thromboembolic Prevention in Patients with Non-valvular Atrial Fibrillation (PREVAIL)

Presenter: David R. Holmes, Jr.

March 08, 2013

Presentation ACC 2013

Randomized Comparison of PtCr-EES vs CoCr-ZES in All-Comers Receiving PCI: The HOST-ASSURE Randomized Trial

Presenter: Hyo-Soo Kim

March 08, 2013

Presentation ACC 2013

Strategies of Clopidogrel Load and Atorvastatin Reload to Prevent Ischemic Cerebral Events in Patients Undergoing Protected Carotid Stenting: Results from the Randomized ARMYDA-9 CAROTID Study

Presenter: Giuseppe Patti

March 08, 2013

Presentation ACC 2013

The ULTIMA Trial

Presenter: Nils Kucher

March 08, 2013

Presentation PCI Outcomes 2013

Case Presentation: DES Restenosis in 2013

Presenter: Philippe Généreux

March 07, 2013

Presentation PCI Outcomes 2013

Clinical Approach to Multi-Vessel CAD

Presenter: Allen Jeremias

March 07, 2013

Presentation PCI Outcomes 2013

Strengths, Limitations and Real-world Implications of Appropriateness Use Criteria

Presenter: Dennis T. Ko

March 07, 2013

Presentation PCI Outcomes 2013

Perspectives on PCI and CABG for Multivessel Disease

Presenter: Ajay J. Kirtane

March 07, 2013

Presentation

Lack of Aspirin Prior to PCI Relatively Common and Strongly Associated with IncreasedIn-Hospital Mortality

Presenter: M. Kenaan

March 07, 2013

Presentation PCI Outcomes 2013

Perspectives on the Selection and Duration of Dual Antiplatelet Therapy

Presenter: Dominick J. Angiolillo

March 07, 2013

Advertisement

Slides

Randomized Trial of LAA Closure vs Warfarin for Stroke/ Thromboembolic Prevention in Patients with Non-valvular Atrial Fibrillation (PREVAIL)

Randomized Comparison of PtCr-EES vs CoCr-ZES in All-Comers Receiving PCI: The HOST-ASSURE Randomized Trial

Strategies of Clopidogrel Load and Atorvastatin Reload to Prevent Ischemic Cerebral Events in Patients Undergoing Protected Carotid Stenting: Results from the Randomized ARMYDA-9 CAROTID Study

The ULTIMA Trial

Case Presentation: DES Restenosis in 2013

Clinical Approach to Multi-Vessel CAD

Strengths, Limitations and Real-world Implications of Appropriateness Use Criteria

Perspectives on PCI and CABG for Multivessel Disease

Lack of Aspirin Prior to PCI Relatively Common and Strongly Associated with IncreasedIn-Hospital Mortality

Perspectives on the Selection and Duration of Dual Antiplatelet Therapy

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content